Area of research
Oncology · Economics and Econometrics
Research interest
Research interests include Cancer survivorship and care, Health Systems, Economic Evaluations, Quality of Life, Childhood Cancer Survivors' Quality of Life, and Lymphoma Diagnosis and Treatment.
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study
Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs
[Ethical Considerations of Including Minors in Clinical Trials Using the Example of the Indicated Prevention of Psychotic Disorders].
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types.
Twice weekly polymerase chain reaction (PCR) surveillance swabs are not as effective as daily antigen testing for containment of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) outbreaks: A modeling study based on real world data from a child and adolescent psychiatry clinic.
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
Effects of a five-day HD-tDCS application to the right IFG depend on current intensity: A study in children and adolescents with ADHD
Comparison between conventional and HD-tDCS of the right inferior frontal gyrus in children and adolescents with ADHD
Minimally important differences for interpreting the EORTC QLQ‐C30 in patients with advanced colorectal cancer treated with chemotherapy
Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy.
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer
Current state of quality of life and patient-reported outcomes research.
Sensitivity to change of the EORTC quality of life module measuring cancer‐related fatigue (EORTC QlQ‐Fa12): Results from the international psychometric validation
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review
Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials
Orbitofrontal Signaling of Future Reward is Associated with Hyperactivity in Attention-Deficit/Hyperactivity Disorder
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group
Improving Interference Control in ADHD Patients with Transcranial Direct Current Stimulation (tDCS)
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients
The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial
Quality of life in long-term survivors following treatment for Hodgkin's disease during childhood and adolescence in the German multicentre studies between 1978 and 2002
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites
Development of an EORTC quality of life phase III module measuring cancer‐related fatigue (EORTC QLQ‐FA13)